http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100647824-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E05Y2900-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E05D2007-128 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E05D15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E05D7-1061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E05D7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F24C15-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 |
filingDate | 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100647824-B1 |
titleOfInvention | Oxatriazacisrisne compound having multi-drug resistance coping resistance and method for preparing same |
abstract | The present invention relates to an oxatriaziricisene compound having a multidrug resistance coping ability and a method for preparing the same. In particular, the oxatriaziricisene compound and derivatives thereof of the present invention can be used for reducing or restoring multi-drug resistance of multi-drug resistant cells or for regulating protein activity associated with multi-drug resistance.n n n Multidrug Resistant, Oxatriazaccirisen, Isoquinoline, [1,4] oxazine, Anticancer Agent |
priorityDate | 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.